Filing Details
- Accession Number:
- 0001179110-13-000807
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-11 20:31:10
- Reporting Period:
- 2013-01-09
- Filing Date:
- 2013-01-11
- Accepted Time:
- 2013-01-11 20:31:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1282660 | R Julianna Wood | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Vp, Public Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-09 | 1,027 | $28.55 | 19,246 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-01-09 | 511 | $30.28 | 19,757 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-01-09 | 3,646 | $35.18 | 23,403 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-01-09 | 1,438 | $37.68 | 24,841 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-01-09 | 6,622 | $85.00 | 18,219 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-01-09 | 1,027 | $0.00 | 1,027 | $28.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-01-09 | 511 | $0.00 | 511 | $30.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-01-09 | 3,646 | $0.00 | 3,646 | $35.18 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-01-09 | 1,438 | $0.00 | 1,438 | $37.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,213 | 2019-03-31 | No | 4 | M | Direct | |
| 8,676 | 2020-03-31 | No | 4 | M | Direct | |
| 13,854 | 2021-03-31 | No | 4 | M | Direct | |
| 21,562 | 2022-03-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 200 | Indirect | Children's Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- 12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
Billionaire Hedge Funds
